GlassScriptPhysician profile
Jennifer P Stone
NPI 1770672347
$1,011.42
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $78.01 · 2021: $66.38 · 2022: $265 · 2023: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.41 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $146.36 | 2019-2023 | |
| Daiichi Sankyo INC. | $129.05 | 2022-2023 | Enhertu |
| Merck Sharp & Dohme LLC | $95.57 | 2021-2023 | Keytruda, Lynparza |
| Astellas Pharma US INC | $89.00 | 2020-2023 | Xtandi |
| E.R. Squibb & Sons, L.L.C. | $60.22 | 2019-2022 | |
| Genentech USA, INC. | $57.45 | 2019-2021 | |
| Glaxosmithkline, LLC. | $49.13 | 2022-2023 | Zejula, Jemperli |
| Incyte Corporation | $47.22 | 2019-2022 | |
| Amgen INC. | $42.32 | 2020-2023 | Kyprolis |
| Taiho Oncology, INC. | $37.36 | 2022-2023 | |
| Organon LLC | $33.95 | 2022 | |
| Abbvie INC. | $33.12 | 2019 | |
| Octapharma USA, INC. | $32.83 | 2019 | |
| Gilead Sciences, INC. | $23.34 | 2023 | Trodelvy |
| Lexicon Pharmaceuticals, INC. | $22.38 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $22.16 | 2023 | Imbruvica |
| Lilly USA, LLC | $21.26 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.38 | 2022 | |
| Clovis Oncology, INC. | $14.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.